Literature DB >> 18607387

CD8(+) T-cell attenuation of cutaneous herpes simplex virus infection reduces the average viral copy number of the ensuing latent infection.

Linda M Wakim1, Claerwen M Jones, Thomas Gebhardt, Christopher M Preston, Francis R Carbone.   

Abstract

During an initial encounter with herpes simplex virus type 1 (HSV-1) it takes several days for an adaptive immune response to develop and for herpes-specific CD8(+) T cells to infiltrate sites of infection. By this time the virus has firmly established itself within the innervating sensory nervous system where it then persists indefinitely. Preventing the establishment of viral latency would require blocking the skin to nervous system transmission of the virus. We wished to examine if CD8(+) T cells present early during acute HSV-1 infection could block this transmission. We show that effector CD8(+) T cells failed to prevent the establishment of HSV latency even when present prior to infection. This lack of blocking likely reflects the delayed infiltration of the CD8(+) T cells into the infected skin. Examination of the kinetics of HSV-1 infection highlighted the rapidity at which the virus infects the sensory ganglia and singled out early viral replication within the skin as an important factor in determining the magnitude of the ensuing latent infection. Though unable to prevent the establishment of latency, CD8(+) T cells could reduce the average viral copy number of the residual latent infection by dampening the skin infection and thus limiting the skin-to-nerve transmission of virus.

Entities:  

Mesh:

Year:  2008        PMID: 18607387     DOI: 10.1038/icb.2008.47

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  33 in total

1.  Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation.

Authors:  Laura K Mackay; Angus T Stock; Joel Z Ma; Claerwen M Jones; Stephen J Kent; Scott N Mueller; William R Heath; Francis R Carbone; Thomas Gebhardt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

2.  Intratumoral Infection with Murine Cytomegalovirus Synergizes with PD-L1 Blockade to Clear Melanoma Lesions and Induce Long-term Immunity.

Authors:  Dan A Erkes; Guangwu Xu; Constantine Daskalakis; Katherine A Zurbach; Nicole A Wilski; Toktam Moghbeli; Ann B Hill; Christopher M Snyder
Journal:  Mol Ther       Date:  2016-06-10       Impact factor: 11.454

3.  Maintenance of T cell function in the face of chronic antigen stimulation and repeated reactivation for a latent virus infection.

Authors:  Laura K Mackay; Linda Wakim; Catherine J van Vliet; Claerwen M Jones; Scott N Mueller; Oliver Bannard; Douglas T Fearon; William R Heath; Francis R Carbone
Journal:  J Immunol       Date:  2012-01-23       Impact factor: 5.422

4.  Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells.

Authors:  Sammy Bedoui; Paul G Whitney; Jason Waithman; Liv Eidsmo; Linda Wakim; Irina Caminschi; Rhys S Allan; Magdalena Wojtasiak; Ken Shortman; Francis R Carbone; Andrew G Brooks; William R Heath
Journal:  Nat Immunol       Date:  2009-04-06       Impact factor: 25.606

5.  Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.

Authors:  David J Davido; Eleain M Tu; Hong Wang; Maria Korom; Andreu Gazquez Casals; P Jahnu Reddy; Heba H Mostafa; Benjamin Combs; Steve D Haenchen; Lynda A Morrison
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

6.  Different patterns of peripheral migration by memory CD4+ and CD8+ T cells.

Authors:  Thomas Gebhardt; Paul G Whitney; Ali Zaid; Laura K Mackay; Andrew G Brooks; William R Heath; Francis R Carbone; Scott N Mueller
Journal:  Nature       Date:  2011-08-14       Impact factor: 49.962

Review 7.  Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.

Authors:  Joshua T Schiffer; Sami L Gottlieb
Journal:  Vaccine       Date:  2017-09-25       Impact factor: 3.641

8.  Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs.

Authors:  Richard Brans; Feng Yao
Journal:  BMC Microbiol       Date:  2010-06-03       Impact factor: 3.605

9.  A novel Cre recombinase imaging system for tracking lymphotropic virus infection in vivo.

Authors:  Bernadette M Dutia; Stuart J Reid; Derek D Drummond; Yvonne Ligertwood; Ian Bennet; Willard Rietberg; Ondine Silvia; Michael A Jarvis; Anthony A Nash
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240

10.  A historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neurones.

Authors:  João T Proença; Heather M Coleman; Viv Connor; Douglas J Winton; Stacey Efstathiou
Journal:  J Gen Virol       Date:  2008-12       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.